Eterna Therapeutics
ERNA
#11171
Rank
C$3.3 M
Marketcap
C$1.95
Share price
-16.56%
Change (1 day)
2.45%
Change (1 year)

EPS for Eterna Therapeutics (ERNA)

EPS in 2026 (TTM): C-$40.38

According to Eterna Therapeutics's latest financial reports the company's current EPS (TTM) is C-$42.00. In 2022 the company made an earnings per share (EPS) of C-$4,512 an increase over its 2021 EPS that were of C-$29,807.

EPS history for Eterna Therapeutics from 2021 to 2026

Annual EPS

Year EPS Change
2026 (TTM)C-$40.38
2022C-$4,512-84.86%
2021C-$29,807

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Sanofi
SNY
C$2.84-106.76%๐Ÿ‡ซ๐Ÿ‡ท France
Baxter
BAX
C-$2.02-95.19%๐Ÿ‡บ๐Ÿ‡ธ USA
Omeros Corporation
OMER
C$2.45-105.84%๐Ÿ‡บ๐Ÿ‡ธ USA
Geron
GERN
C-$0.11-99.73%๐Ÿ‡บ๐Ÿ‡ธ USA
Genetic Technologies
GENE
N/AN/A๐Ÿ‡ฆ๐Ÿ‡บ Australia
Teva Pharmaceutical Industries
TEVA
C$0.65-101.54%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel
Bio-Techne
TECH
C$1.68-103.99%๐Ÿ‡บ๐Ÿ‡ธ USA